{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:47:13Z","timestamp":1792079233834,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12010-026-05927-z","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:07:55Z","timestamp":1790057275000},"page":"9020-9038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL1\/USP48 Axis Stabilizes LCN2 Expression to Promote the Malignant Phenotypes of Cutaneous Squamous Cell Carcinoma"],"prefix":"10.1007","volume":"198","author":[{"given":"Xiuqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"5927_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073478","author":"ML Hedberg","year":"2022","unstructured":"Hedberg, M. L., Berry, C. T., Moshiri, A. S., et al. (2022). Molecular mechanisms of cutaneous squamous cell carcinoma. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23073478","journal-title":"International Journal of Molecular Sciences"},{"key":"5927_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s12325-022-02044-1","volume":"39","author":"A Villani","year":"2022","unstructured":"Villani, A., Potestio, L., Fabbrocini, G., & Scalvenzi, M. (2022). New emerging treatment options for advanced basal cell carcinoma and squamous cell carcinoma. Advances in Therapy, 39, 1164\u20131178.","journal-title":"Advances in Therapy"},{"key":"5927_CR3","volume":"14","author":"S Zheng","year":"2024","unstructured":"Zheng, S., Yu, H., Zhang, J., et al. (2024). Prediction of relative survival trends in patients with cutaneous squamous cell carcinoma using a model-based period analysis: A retrospective analysis of the surveillance, epidemiology, and end results database. British Medical Journal Open, 14, Article e086488.","journal-title":"British Medical Journal Open"},{"key":"5927_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020171","author":"L Fania","year":"2021","unstructured":"Fania, L., Didona, D., Di Pietro, F. R., et al. (2021). Cutaneous squamous cell carcinoma: From pathophysiology to novel therapeutic approaches. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9020171","journal-title":"Biomedicines"},{"key":"5927_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jdv.17709","volume":"36","author":"C Dessinioti","year":"2022","unstructured":"Dessinioti, C., Pitoulias, M., & Stratigos, A. J. (2022). Epidemiology of advanced cutaneous squamous cell carcinoma. Journal of the European Academy of Dermatology and Venereology, 36, 39\u201350.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"5927_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","volume":"78","author":"JYS Kim","year":"2018","unstructured":"Kim, J. Y. S., Kozlow, J. H., Mittal, B., et al. (2018). Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology, 78, 560\u2013578.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"5927_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/life15081257","author":"M Kaufhold","year":"2025","unstructured":"Kaufhold, M., Asadi, S., Ghoreishi, Y., et al. (2025). Cutaneous squamous cell carcinoma risk factors: Are current criteria still valid? A retrospective, monocenter analysis. Life. https:\/\/doi.org\/10.3390\/life15081257","journal-title":"Life"},{"key":"5927_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","volume":"25","author":"S Delaunay","year":"2024","unstructured":"Delaunay, S., Helm, M., & Frye, M. (2024). RNA modifications in physiology and disease: Towards clinical applications. Nature Reviews Genetics, 25, 104\u2013122.","journal-title":"Nature Reviews Genetics"},{"key":"5927_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100001","volume":"22","author":"Z Wu","year":"2025","unstructured":"Wu, Z., Shen, N., Song, P., Wang, B., & Li, C. (2025). SP1-mediated WTAP exacerbates the progression of colon adenocarcinoma by m6A methylation of KLK8. Current Proteomics, 22, Article 100001.","journal-title":"Current Proteomics"},{"key":"5927_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui, L., Ma, R., Cai, J., et al. (2022). RNA modifications: Importance in immune cell biology and related diseases. Signal Transduction and Targeted Therapy, 7, 334.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"5927_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1491763","volume":"15","author":"W Zhou","year":"2024","unstructured":"Zhou, W., Yi, Y., Cao, W., Zhong, X., & Chen, L. (2024). Functions of METTL1\/WDR4 and QKI as m7G modification - related enzymes in digestive diseases. Frontiers in Pharmacology, 15, Article 1491763.","journal-title":"Frontiers in Pharmacology"},{"key":"5927_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/or.2025.1637372","volume":"19","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Chen, Y., Li, M., Zhou, X., & Song, Q. (2025). METTL1 in human cancers: Recognition of their functions, mechanisms and therapeutic value. Oncology Reviews, 19, Article 1637372.","journal-title":"Oncology Reviews"},{"key":"5927_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111145","volume":"118","author":"R Dong","year":"2024","unstructured":"Dong, R., Wang, C., Tang, B., et al. (2024). WDR4 promotes HCC pathogenesis through N(7)-methylguanosine by regulating and interacting with METTL1. Cellular Signalling, 118, Article 111145.","journal-title":"Cellular Signalling"},{"key":"5927_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41420-025-02304-3","volume":"11","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Chen, T., Zhang, F., et al. (2025). METTL1 coordinates cutaneous squamous cell carcinoma progression via the m7G modification of the ATF4 mRNA. Cell Death Discov., 11, 27.","journal-title":"Cell Death Discov."},{"key":"5927_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu, F., Chen, J., Li, K., et al. (2024). Ubiquitination and deubiquitination in cancer: From mechanisms to novel therapeutic approaches. Molecular Cancer, 23, 148.","journal-title":"Molecular Cancer"},{"key":"5927_CR16","first-page":"543","volume":"21","author":"H Miao","year":"2024","unstructured":"Miao, H., Yu, G., Minmin, Y., & Changsong, L. (2024). Identification of a ubiquitination-related signature for ovarian cancer based on 101 combinations of machine learning methods. Current Proteomics., 21, 543\u2013560.","journal-title":"Current Proteomics."},{"key":"5927_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043219","author":"H Kitamura","year":"2023","unstructured":"Kitamura, H. (2023). Ubiquitin-specific proteases (USPs) and metabolic disorders. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms24043219","journal-title":"International Journal of Molecular Sciences"},{"key":"5927_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.apsb.2024.01.006","volume":"14","author":"C Cheng","year":"2024","unstructured":"Cheng, C., Yao, H., Li, H., et al. (2024). Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis. Acta Pharmaceutica Sinica B, 14, 1624\u20131643.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"5927_CR19","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","volume":"81","author":"L Du","year":"2021","unstructured":"Du, L., Li, Y., Kang, M., et al. (2021). USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization. Cancer Research, 81, 3822\u20133834.","journal-title":"Cancer Research"},{"key":"5927_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.747135","volume":"11","author":"H Shen","year":"2021","unstructured":"Shen, H., Wang, Z., Huang, A., et al. (2021). Lipocalin 2 is a regulator during macrophage polarization induced by soluble worm antigens. Frontiers in Cellular and Infection Microbiology, 11, Article 747135.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"5927_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","volume":"37","author":"X Xiao","year":"2017","unstructured":"Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017). Lipocalin 2: An emerging player in iron homeostasis and inflammation. Annual Review of Nutrition, 37, 103\u2013130.","journal-title":"Annual Review of Nutrition"},{"key":"5927_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07153-z","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang, Z., Li, Y., Qian, Y., et al. (2024). Tumor-secreted LCN2 impairs gastric cancer progression via autocrine inhibition of the 24p3R\/JNK\/c-Jun\/SPARC axis. Cell Death & Disease, 15, Article 756.","journal-title":"Cell Death & Disease"},{"key":"5927_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-023-02618-z","volume":"42","author":"Z Huang","year":"2023","unstructured":"Huang, Z., Rui, X., Yi, C., et al. (2023). Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling. Journal of Experimental & Clinical Cancer Research, 42, 60.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"5927_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena, I., Roshan, A., Gerstung, M., et al. (2015). Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science., 348, 880\u2013886.","journal-title":"Science."},{"key":"5927_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/jid.2014.376","volume":"135","author":"P Riihil\u00e4","year":"2015","unstructured":"Riihil\u00e4, P., Nissinen, L., Farshchian, M., et al. (2015). Complement factor I promotes progression of cutaneous squamous cell carcinoma. The Journal of Investigative Dermatology, 135, 579\u2013588.","journal-title":"The Journal of Investigative Dermatology"},{"key":"5927_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2020.11.009","volume":"83","author":"MP Kashyap","year":"2022","unstructured":"Kashyap, M. P., Sinha, R., Mukhtar, M. S., & Athar, M. (2022). Epigenetic regulation in the pathogenesis of non-melanoma skin cancer. Seminars in Cancer Biology, 83, 36\u201356.","journal-title":"Seminars in Cancer Biology"},{"key":"5927_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-01988-w","volume":"23","author":"P Zhang","year":"2022","unstructured":"Zhang, P., Li, L., Wang, B., et al. (2022). MiR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt\/\u03b2-catenin signaling pathway via regulating USP48. Respiratory Research, 23, Article 93.","journal-title":"Respiratory Research"},{"key":"5927_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1099\/vir.0.025064-0","volume":"92","author":"B Akg\u00fcl","year":"2011","unstructured":"Akg\u00fcl, B., Bauer, B., Zigrino, P., et al. (2011). Upregulation of lipocalin-2 in human papillomavirus-positive keratinocytes and cutaneous squamous cell carcinomas. Journal of General Virology, 92, 395\u2013401.","journal-title":"Journal of General Virology"},{"key":"5927_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12964-019-0434-3","volume":"17","author":"Y Lu","year":"2019","unstructured":"Lu, Y., Dong, B., Xu, F., et al. (2019). CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition. Cell Communication and Signaling: CCS, 17, 118.","journal-title":"Cell Communication and Signaling: CCS"},{"key":"5927_CR30","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/1878-0261.13529","volume":"17","author":"Q Xia","year":"2023","unstructured":"Xia, Q., Du, Z., Chen, M., et al. (2023). A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer. Molecular Oncology, 17, 2451\u20132471.","journal-title":"Molecular Oncology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05927-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:16:55Z","timestamp":1792077415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05927-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5927"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05927-z","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"8 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human study: The present study was approved by the ethical review committee of Qilu Hospital of Shandong University with approval No. KYLL-2026-04(YJ)-069. All procedures involving human disease tissue samples complied with the Declaration of Helsinki and its subsequent amendments. Written informed consent was obtained from all enrolled patients. All tissue specimens were fully anonymized to protect patient privacy and were only used for the basic scientific research of this study, not for other purposes.Animal study: All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Qilu Hospital of Shandong University with approval No. KYLL-2026-04(YJ)-069-1. The animal study strictly followed the ARRIVE guidelines and the 3Rs principle (Replacement, Reduction, Refinement). All surgical procedures were performed under standardized anesthesia, and every effort was made to minimize animal pain and stress. Humane euthanasia was conducted at the end of experiments in accordance with the national standard \u201cGuidelines for Ethical Review of Laboratory Animal Welfare\u201d (GB\/T 35892\u20132018).","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}